COVID inequity: In Africa, at-home tests are scarce, costly

February 4, 2022 |
Such a deal! Covid-19 therapies appear cost-effective…for now
Pfizer criticized over patent strategy for Covid-19 pill, despite a deal to broaden access in poor countries
Related Posts
Access to Medicines

Pharma’s alleged “brea...
PEPFAR Watch

PEPFAR is Rolling the Cloc...
Access to Medicines

Pharma Pricing Secrecy Run...